Patient Note — 161522

4/8/26, 3:58 PM Print Preview [PATIENT_NAME] DOB: [DOB] (69 yo M) Acc No. [ACCOUNT_ID] DOS: 03/24/2026 [PATIENT_NAME] 69 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] DOVER CT, ALEXANDRIA, VA-[ZIP] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Anthem Healthkeepers Plus PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Fair Oaks Structured Data: How did you hear about us? : Other; Patient's temperature : 0; : 10/27/2022 03/24/2026 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. FU History of Present Illness General Urology: 3/24/2026 FU OAB, SUI, ED, and PCa Failed solifenacin and trospium. Uncertain if he took duloxetine. ================================================================== PSA: <0.1 (February 2026), 0.00 (Oct 2024); 0.00 (July 2024), 0.00 (April 2024), 0.00 (Jan 2024), 8.26 ng/ml (10/27/22), 6.5 ng/ml (9/22), 4.6 ng/ml (5/22), 3.05 ng/ml (2/22) S/P Prostatectomy, Path: (1) 75 cc (2) Gleason 3+4=7 (3) Negative margins, no ECE (4) pT2pN0 (July 2023) 4Kscore: 17.3 % (10/27/22) Decipher: 0.31 Cysto (Oct'24): bladder was filled to 180cc, mild SUI, short length urethra; good sphincter control; +urgency. Prostate Cancer: 69 yM with hx of Gleason 3+4=7 prostate cancer s/p prostatectomy pT2N0, negative margins, July 2023, presents for 6 week follow up and PSA review. ==================================== The patient's previous work-up history is listed below: PSA: <0.1 (February 2026), 0.00 (Oct 2024); 0.00 (July 2024), 0.00 (April 2024), 0.00 (Jan 2024), 8.26 ng/ml (10/27/22), 6.5 ng/ml (9/22), 4.6 ng/ml (5/22), 3.05 ng/ml (2/22) Prostatectomy Path: (1) 75 cc (2) Gleason 3+4=7 (3) Negative margins, no ECE (4) pT2pN0 (July 2023) 4Kscore: 17.3 % (10/27/22) Decipher: 0.31 Cysto (Oct'24): bladder was filled to 180cc, mild SUI, short length urethra; good sphincter control; +urgency. Prostate Cancer (localized): Prostate Bx information Date of biopsy 05-2023 Fusion biopsy? No Gleason Score (all positives) 3+3=6 (Grade Group 1), 3+4=7 (Grade Group 2) Progress Note: [PROVIDER_NAME], MD 03/24/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/08/2026 06:28 AM EDT 1/5 4/8/26, 3:58 PM Print Preview [PATIENT_NAME] DOB: [DOB] (69 yo M) Acc No. [ACCOUNT_ID] DOS: 03/24/2026 Total cores positive (not including fusion) 5 Largest % core involvement 70 Family history Prostate cancer? No Staging Clinical Stage - BIOPSY T1c - tumor identified by needle biopsy AUA Risk Stratification favorable intermediate risk (Grade Group 1 with PSA 10 - < 20, Grade Group 2 with PSA < 10) Bx Genomics Decipher biopsy testing in progress Erectile Dysfunction screening: Penile US Date 10/15/2024 Trimix injected (cc) 0.3 Arterial flow (max, cm/s) 44.58 / 44.58 Venous flow (max, cm/s) 8.99 / 0.00 Findings Left side venous leak PUC Referring Provider P Desai Also with hx of erectile dysfunction (ED), currently on sildenafil and tad